Lunit said it signed contracts to supply its AI solutions to France's largest teleradiology network, TeleDiag, and the Central Center of the Portuguese Cancer League (Liga Portuguesa Contra o Cancro, LPCC), a prominent nonprofit organization in Portugal.

Lunit has recently secured a contract with TeleDiag to provide its chest X-ray AI analysis solution, Lunit INSIGHT CXR.

Established in 2008 by French physicians, TeleDiag leverages digital remote technology to address healthcare inequalities for the underserved populations and facilitates faster diagnoses in emergency situations.

With over 600 radiologists diagnosing more than 600,000 patients annually across 300 partner institutions, TeleDiag's adoption of Lunit INSIGHT CXR, chosen over other global competitors for its superior technology, marks a significant validation of Lunit's product excellence.

Lunit has also entered into an agreement with LPCC's Central Center to supply its mammography AI analysis solution, Lunit INSIGHT MMG.

Founded in 1941, LPCC contributes to Portugal's cancer response programs through cancer prevention campaigns, early diagnosis programs, and support services for patients and their families.

The LPCC Central Center, located in Coimbra, one of Portugal's largest city, manages the national breast cancer screening program.

Prior to this agreement, the center conducted an extensive internal validation using its patient data to confirm Lunit's AI solution's effectiveness.

Over the next three years, the LPCC Central Center plans to utilize Lunit INSIGHT MMG to conduct approximately 100,000 annual screenings as part of the government's breast cancer screening program.

"This supply agreement with Western European countries reconfirms our technological and product superiority over competitors,” Lunit CEO Suh Beom-suk said. “The expansion of our supply in Europe, where there is a high demand for advanced medical services provided through AI, will play a crucial role in Lunit's leap to become a leading global medical AI company."

Lunit is strengthening its partnerships with global medical device companies in Europe and expanding its sales network across the continent through Lunit Europe Holdings, a subsidiary established in the Netherlands in February of last year.